Introduction

Autoimmune diseases have a great role in growing health concerns globally, affecting millions of individuals with conditions that range from mild joint aches to life-threatening systemic disorders. It occurs when the body's immune system mistakenly attacks and damages its tissues.¹ This fundamental breakdown in self-tolerance leads to chronic inflammation and tissue damage with potentially devastating consequences for affected individuals. 

The mechanisms underlying this immune dysfunction involve complex interactions between genetic predisposition, environmental triggers, and disbalanced immune responses that collectively transform protective immunity into self-autoimmunity in the immune system, producing autoantibodies that target various body parts, such as joints, skin, or organs.¹

Mechanisms of autoimmunity

The shift from normal immune function to autoimmunity involves several important steps that collectively break down the barriers protecting against self-reactivity.² This process begins with the activation of self-reactive lymphocytes that have eluded central tolerance mechanisms, which are then expanded, differentiated into effector cells, and infiltrate the tissue.² The particular triggers that initiate this cascade vary per illness, but they often require a mix of genetic vulnerability and environmental exposures that alter immune homeostasis.²

Another important component in the development of autoimmunity is the disruption of regulatory systems that typically control self-reactive immune responses. Regulatory T cells (Tregs) often prevent autoimmunity by inhibiting the activation and proliferation of autoreactive T cells. Treg function or number defects have been linked to various autoimmune diseases, emphasising their critical role in self-tolerance. Similarly, tolerogenic dendritic cells, which usually support immunological tolerance through numerous pathways, can become dysregulated in autoimmune diseases, further impairing self-tolerance mechanisms.

Cells involved in autoimmunity

• Rogue Immune Cells: Recent research has shown that some immune cells, particularly killer T cells, can become "rogue" due to genetic mutations⁵. These cells bypass immune checkpoints and attack the body's tissues⁵
• T-helper Cells: Different classes of T-helper lymphocytes, especially Th1, Th2, and Th17, play crucial roles in promoting autoimmune diseases by stimulating various immune responses⁶

Factors/triggers in autoimmunity

Autoimmune diseases can be triggered by various factors, with the most common triggers including:

Genetic factors

Certain gene variants can predispose individuals to autoimmune diseases.^2,3 For example, researchers have identified "lymphoma driver mutations," including a variant of the CARD11 gene, which allows rogue immune cells to evade tolerance checkpoints and multiply unchecked.²

Molecular Mimicry: Structural similarities between self-antigens and foreign antigens (especially microbial) can lead to autoimmune responses.

Environmental triggers

Several environmental factors can trigger autoimmune responses:

• Infections: Viral and bacterial infections can potentially trigger autoimmune responses³
• Chemical exposure: Certain chemicals, including occupational and environmental toxins, have been linked to autoimmune diseases³
• Sun exposure: Excessive sunlight can act as a trigger for certain autoimmune conditions²
• Smoking: Tobacco use has been associated with an increased risk of developing autoimmune diseases, particularly rheumatoid arthritis²

Physiological factors

• Stress: Both physical and psychological stress have been implicated in the development of autoimmune diseases³
• Hormonal changes: Sex hormones may play a role, as more females develop autoimmune disorders than males³
• Dietary components: Certain foods, such as gluten for celiac disease patients, can trigger autoimmune responses⁴

Common autoimmune diseases

Some of the most prevalent autoimmune diseases include:

1. Rheumatoid Arthritis (mainly affecting joints) 
2. Systemic lupus erythematosus (affecting multiple organ systems)
3. Inflammatory bowel disease (Crohn's disease, ulcerative colitis)
4. Type 1 diabetes (destroying insulin-producing pancreatic cells)
5. Multiple sclerosis (affecting the central nervous system)
6. Psoriasis
7. Thyroid diseases(attack the thyroid gland, often leading to hypothyroidism)

Rheumatoid arthritis (RA)

RA is a chronic inflammatory disease that primarily affects the joints, causing pain, swelling, and loss of function. 

Treatment strategies include:

• Disease-modifying antirheumatic drugs (DMARDs) to slow progression
• Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief
• Physical therapy to maintain joint flexibility
• In severe cases, surgery to repair damaged joints

Systemic lupus erythematosus (Lupus)

SLE is a complex autoimmune disease affecting multiple organ systems, including the skin, joints, kidneys, and nervous system.

Treatment strategies include:

• Antimalarial drugs like hydroxychloroquine
• Corticosteroids to reduce inflammation
• Immunosuppressants in severe cases
• Sun protection and stress management

Inflammatory bowel disease (IBD)

IBD includes Crohn's disease and ulcerative colitis, characterised by chronic inflammation of the gastrointestinal tract.

Treatment strategies include

• Anti-inflammatory drugs (e.g., aminosalicylates)
• Immunosuppressants
• Biologic therapies
• Dietary modifications
• Surgery in severe cases

Type 1 diabetes (T1D)

T1D results from the autoimmune destruction of insulin-producing pancreatic β-cells, leading to high blood sugar levels.

Treatment strategies include

• Insulin therapy (injections or pump)
• Regular blood glucose monitoring
• Carbohydrate counting and meal planning
• Regular exercise

Multiple sclerosis (MS)

MS is an autoimmune disease affecting the central nervous system. The immune cell attacks the protective covering of nerve fibres, causing communication problems between the brain and the rest of the body.

Treatment strategies include

• Disease-modifying therapies to slow progression
• Corticosteroids for acute attacks
• Physical therapy and occupational therapy
• Medications to manage specific symptoms like fatigue or muscle spasms (twitch)

Psoriasis

Psoriasis is an autoimmune condition causing rapid skin cell turnover, which results in scaly, thick, red patches on the skin.

Treatment strategies include

• Topical treatments (corticosteroids, vitamin D analogues)
• Phototherapy (light therapy)
• Systemic medications for severe cases (methotrexate, biologics)

Thyroid diseases

Autoimmune thyroid diseases can lead to hypothyroidism (Hashimoto's) or hyperthyroidism (Graves' disease).

Treatment approaches:

1. Hashimoto's thyroiditis:
   • Thyroid hormone replacement (levothyroxine)
   • Regular monitoring of thyroid hormone levels
2. Graves' disease:
   • Antithyroid medications
   • Radioactive iodine therapy
   • Surgery (thyroidectomy) in some cases

General symptoms in autoimmunity

Autoimmune diseases present a wide range of symptoms depending on the specific condition and affected body systems. It can affect various parts of the body, leading to diverse symptoms:

• Inflammation: Redness, swelling, heat, and pain in affected areas
• Fatigue: Often severe and persistent
• Joint pain and stiffness: Common in conditions like rheumatoid arthritis
• Skin issues: Rashes, lesions, or changes in skin texture
• Gastrointestinal problems: Abdominal pain, diarrhoea, or constipation
• Neurological symptoms: Numbness, tingling, or cognitive difficulties

Management strategies

Current management approaches focus on controlling the immune response and managing symptoms:

Medications

• Immunosuppressants: To reduce immune system activity
• Corticosteroids: For rapid reduction of inflammation
• Biologics: Targeted therapies that focus on specific parts of the immune system
• NSAIDs: To manage pain and inflammation
• Hormone replacements: For conditions affecting hormone-producing glands^{1, 4}

Lifestyle modifications

• Anti-inflammatory diet: Emphasising whole foods and eliminating potential trigger foods
• Stress reduction: Through mindfulness practices and stress management techniques
• Regular exercise: To improve muscle strength and overall health
• Adequate sleep: To support immune function and reduce fatigue

Functional medicine practitioners often develop tailored approaches that address underlying imbalances and individual triggers.

Recent advances and future directions

A shift towards more targeted, personalised approaches in autoimmune disease treatment, potentially offering improved efficacy with fewer side effects compared to traditional broad immunosuppression.

Cell-based therapies

Mesenchymal stromal cells (MSCs), regulatory T cells (Tregs), and myeloid-derived suppressor cells are being explored for their immunosuppressive properties. Clinical trials have shown promising results in conditions like rheumatoid arthritis.⁵

CAR-T cell therapy

Originally developed for cancer treatment, CAR-T cell therapy is now being adapted for autoimmune diseases.⁶ This approach involves engineering a patient's T cells to selectively target and eliminate self-reactive immune cells while preserving normal immune function.⁶ 

Precision therapies

Researchers are developing new generations of T cell therapy approaches, such as CRISPR-based engineering of chimeric autoantigen-T cell receptors (CATCR). These therapies aim to reprogram a patient's T cells to selectively eliminate problematic immune cells without compromising overall immune function.

Gut microbiome interventions

Emerging research focuses on the role of the gut microbiome in autoimmune diseases, with potential interventions targeting gut health to modulate immune responses.

Conclusion

Autoimmune diseases result from a basic breakdown in the immune system's ability to identify self from non-self, resulting in misdirected immune responses that harm normal tissues. These disorders are caused by a complicated interplay between genetic predisposition, environmental stimuli, and dysregulated immune responses, all of which lead to chronic inflammation and tissue death. Understanding these pathways has changed therapeutic approaches, with more targeted interventions replacing non-specific immunosuppression. As our understanding of autoimmunity evolves, the goal of restoring real immunological tolerance - essentially "reprogramming" the immune system to see self-tissues as non-threatening - becomes clearer. Such treatments will address the underlying cause of autoimmune disorders rather than just controlling their symptoms, potentially providing long-term remedies for conditions that today necessitate lifetime care.